# Setmelanotide for POMC and LEPR deficiency obesity: phase 3

Source: https://pepvault.app/research/setmelanotide-clement-2020

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Setmelanotide](https://pepvault.app/research#setmelanotide)

Clinical trial · people

# Setmelanotide: 80% (POMC) and 45% (LEPR) lost at least 10% weight

Checked against the paper November 2026 Clinical trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

This paper shows setmelanotide's effect in two rare genetic causes of obesity, not in common obesity.

- **Kind:** Clinical trial
- **Studied in:** People
- **Published:** 2020
- **Journal:** Lancet Diabetes Endocrinol

## What they tested

The teams tested whether setmelanotide reduces weight and hunger in people with severe obesity caused by POMC or LEPR deficiency, rare inherited gene changes in the body's weight-control pathway.

## How the study was done

Two single-arm, open-label phase 3 trials (everyone got the drug and knew it) at 10 hospitals enrolled people aged 6 or older: 10 in the POMC trial and 11 in the LEPR trial. After 12 weeks on the drug, those who lost at least 5 kg (or 5% if they weighed under 100 kg) entered an 8-week blinded phase with 4 weeks each of drug and placebo (a dummy shot), then 32 more weeks on the drug.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At about 1 year, 80% of POMC participants and 45% of LEPR participants had lost at least 10% of their starting weight. In participants aged 12 or older who passed the early weight-loss cutoff, the worst-hunger score fell by 27.1% in the POMC trial (7 people) and 43.7% in the LEPR trial (7 people). Injection site reactions happened in everyone, hyperpigmentation (skin darkening) in all POMC participants, and nausea and vomiting were also seen. There were no serious treatment-related side effects in either trial.

## What it doesn’t show

Both trials were very small, open-label and had no comparison group for the main 1-year result, and hunger was measured only in people who responded early. The trials were funded by Rhythm Pharmaceuticals.

## The paper

Clément et al. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Lancet Diabetes Endocrinol. 2020.

- [PubMed (PMID 33137293)](https://pubmed.ncbi.nlm.nih.gov/33137293/)
- [The paper (DOI 10.1016/S2213-8587(20)30364-8)](https://doi.org/10.1016/S2213-8587%2820%2930364-8)
- [ClinicalTrials.gov (NCT03287960)](https://clinicaltrials.gov/study/NCT03287960)

## The compound

- [Setmelanotide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

## With this study

### Setmelanotide

- [Setmelanotide: the full reference](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

### Studies

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026)
- [Setmelanotide: 16.5% BMI drop at 52 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-transcend-2026)
- [Setmelanotide: patients reported less hunger, more energy in TRANSCEND](https://pepvault.app/research/setmelanotide-transcend-2026-42528856)
- [All 8 studies](https://pepvault.app/research#setmelanotide)

### Compared with

- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Open-label](https://pepvault.app/glossary/open-label)

## More studies on Setmelanotide

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026) Meta-analysis · people · 2026
- [Setmelanotide: 16.5% BMI drop at 52 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-transcend-2026) Randomized trial · people · 2026
- [Setmelanotide: patients reported less hunger, more energy in TRANSCEND](https://pepvault.app/research/setmelanotide-transcend-2026-42528856) Clinical trial · people · 2026
- [Setmelanotide: mean BMI fell 18% at 52 weeks in ages 2-5 (VENTURE)](https://pepvault.app/research/setmelanotide-venture-2025) Clinical trial · people · 2025
- [Setmelanotide: 15% mean BMI drop at 16 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-roth-2024) Clinical trial · people · 2024
- [Setmelanotide: quality of life rose after 52 weeks in Bardet-Biedl](https://pepvault.app/research/setmelanotide-forsythe-2023) Clinical trial · people · 2023
- [Every study on Setmelanotide](https://pepvault.app/research#setmelanotide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Setmelanotide

- [Setmelanotide: the full reference](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)

### Studies

- [Setmelanotide: injection-site reactions in 96% in pooled trials](https://pepvault.app/research/setmelanotide-sridharan-2026)
- [Setmelanotide: 16.5% BMI drop at 52 weeks in hypothalamic obesity](https://pepvault.app/research/setmelanotide-transcend-2026)
- [Setmelanotide: patients reported less hunger, more energy in TRANSCEND](https://pepvault.app/research/setmelanotide-transcend-2026-42528856)
- [All 8 studies](https://pepvault.app/research#setmelanotide)

### Compared with

- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Open-label](https://pepvault.app/glossary/open-label)

<!--promo-->

PepVault for iPhone

## Taking setmelanotide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Setmelanotide](https://pepvault.app/research#setmelanotide)

## The library

- [Setmelanotide](https://pepvault.app/peptides/setmelanotide)
- [Setmelanotide dose guide](https://pepvault.app/lab/dosage/setmelanotide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
